Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Alison Jones joins PDA as stakeholder engagement director

The Pharmacists Defence Association (PDA) has appointed Alison Jones as the director of stakeholder engagement.

She will also manage the PDA's policy department until a permanent director of policy is appointed, the PDA said in a press release.


Jones previously served as government affairs manager at McKesson UK, having worked for Lloyds Pharmacy, and the wider Celesio/McKesson group since 2003.

“This new role will enhance the PDA’s work, ensuring the voices and interests of individual pharmacists are heard throughout decision making in the sector, the health system and beyond, across the UK,” the association said.

“I am delighted to be joining the PDA in this exciting new role,” said Jones. “My main objective will be to positively support and promote the interests of employed and locum pharmacists working in all settings across the UK.

"I will be looking at emerging policies and working with colleagues and members to develop stakeholder campaigns which address important issues affecting individual pharmacists and ensuring that opportunities are fully explored.”

Mark Koziol, the PDA chair, added: “I am delighted to welcome Alison into the leadership team in an important new role to our structure. The positive influence that pharmacists can have through the PDA grows as our membership numbers continue to increase and as we do more and more as a Defence Association, an Independent Trade Union and as part of Equality, Diversity and Inclusion Networks. I am sure Alison will be an asset to an already strong team.”

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less